Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Oral intake of mesoporous silica is safe and well tolerated in male humans
Stockholm University, Faculty of Science, Department of Molecular Biosciences, The Wenner-Gren Institute.
Show others and affiliations
Number of Authors: 102020 (English)In: PLOS ONE, E-ISSN 1932-6203, Vol. 15, no 10, article id e0240030Article in journal (Refereed) Published
Abstract [en]

Background

Precisely engineered mesoporous silica has been shown to induce weight loss in mice, but whether it is safe to use in humans have not investigated.

Objective

The aim was to determine whether oral dosing, up to 9 grams/day, of precisely engineered mesoporous silica as a food additive can be used safely in male humans.

Design

This single blinded safety study consisted of two study arms including 10 males each (18-35 years). One arm consisted of participants with normal weight and one with obesity. After a placebo run-in period, all subjects were given porous silica three times daily, with increasing dose up to 9 grams/day (Phase 1). Subjects with obesity continued the study with highest dose for additional 10 weeks (Phase 2).

Results

All participants completed Phase 1 and 90% completed Phase 2, with approximately 1% missed doses. Participants reported no abdominal discomfort, and changes in bowel habits were minor and inconsistent. The side effects observed were mild and tolerable, biomarkers did not give any safety concern, and no severe adverse events occurred.

Conclusion

Mesoporous silica intake of up to 9 grams/day can be consumed by males without any major adverse events or safety concerns.

Place, publisher, year, edition, pages
2020. Vol. 15, no 10, article id e0240030
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:su:diva-187634DOI: 10.1371/journal.pone.0240030ISI: 000577103500003PubMedID: 33007031OAI: oai:DiVA.org:su-187634DiVA, id: diva2:1516474
Available from: 2021-01-12 Created: 2021-01-12 Last updated: 2022-02-25Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Hagman, EmiliaKupferschmidt, NataliaBengtsson, ToreDanielsson, Pernilla

Search in DiVA

By author/editor
Hagman, EmiliaKupferschmidt, NataliaBengtsson, ToreDanielsson, Pernilla
By organisation
Department of Molecular Biosciences, The Wenner-Gren Institute
In the same journal
PLOS ONE
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 71 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf